삼성서울병원

Ko En
의료진 검색
찾으실 의료진명을 입력하여 검색해주세요.

내분비대사내과 정재훈 교수

진료분야
갑상선질환
진료일정 05 月
날짜
목
01
금
02
토
03
일
04
월
05
화
06
수
07
목
08
금
09
토
10
일
11
월
12
화
13
수
14
목
15
금
16
토
17
일
18
월
19
화
20
수
21
목
22
금
23
토
24
일
25
월
26
화
27
수
28
목
29
금
30
토
31
오전
오후
진료일정 06 月
날짜
일
01
월
02
화
03
수
04
목
05
금
06
토
07
일
08
월
09
화
10
수
11
목
12
금
13
토
14
일
15
월
16
화
17
수
18
목
19
금
20
토
21
일
22
월
23
화
24
수
25
목
26
금
27
토
28
일
29
월
30
오전
오후
본원외래 본원클리닉 본원육아상담 암병원외래 암병원클리닉 암병원육아상담

학력

학력
1999.08 서울대학교 의과대학원 의학과 (박사)
1995.02 서울대학교 의과대학원 의학과 (석사)
1985.02 서울대학교 의과대학 의학과 졸업 (의학사)

경력

경력
2007.10 ~현재 성균관대학교 의과대학 내과 교수
1994.05 ~현재 삼성서울병원 내분비-대사 내과 전문의
2017.04 ~ 2021.03 삼성서울병원 내과 과장
2017.04 ~ 2021.03 성균관대학교 의과대학 내과학교실 주임교수
2013.08 ~ 2017.03 삼성서울병원 갑상선센터장
2011.11 ~ 2017.03 성균관의대 삼성서울병원 내분비-대사 내과 과장
2007.09 ~ 2011.10 삼성서울병원 진료의뢰센터 센터장
2005.05 ~ 2009.08 삼성서울병원 암센터 갑상선암팀장
2001.10 ~ 2007.09 성균관대학교 의과대학 내과 부교수
2001.01 ~ 2002.02 미국 오하이오 의과대학 방문연구원
1997.03 ~ 2001.09 성균관대학교 의과대학 내과 조교수
2000.02 ~ 2000.12 미국 국립보건원 (NIH) NIDDK 방문연구원
1996.08 내분비-대사 내과 분과전문의 자격 취득
1992.05 ~ 1994.04 서울대학교병원 내분비-대사 내과 전임의
1993.01 ~ 1993.04 미국 국립보건원 (NIH) NIDDK 방문연구원
1990.05 ~ 1992.04 공군 방공포병사령부 의무실장
1989.04 ~ 1990.04 육군 보병 제5사단 내과 군의관
1989.03 내과 전문의 자격 취득
1986.02 ~ 1989.02 서울대학교병원 내과 레지던트 과정 수료
1985.03 ~ 1986.02 서울대학교병원 인턴과정 수료

학회활동

학회활동
2010.03 ~ 현재 미국내분비학회 회원
2005.03 ~ 현재 대한내분비학회 평의원
2002.03 ~ 현재 대한갑상선학회 회원
1992.03 ~ 현재 아시아-오세아니아 갑상선학회 (AOTA) 회원
1986.03 ~ 현재 대한내과학회 회원
1986.03 ~ 현재 대한내분비학회 회원
논문
  • THYROID 2024 10.1089/thy.2024.0270 Graves' Disease and the Risk of Type 2 Diabetes: A Korean Population-Based Study Cho, YY; Kim, B; Jin, SM; Jung, CH; Mok, JO; Kim, SW; Chung, JH; Han, KD; Kim, TH
    View PubMed
  • CANCER IMMUNOL IMMUN 2024 10.1007/s00262-024-03852-w Biomarker role of thyroid irAE and PD-L1 positivity in predicting PD-1 blockade efficacy in patients with non-small cell lung cancer Kim, HI; Kim, WG; Kim, M; Ko, NG; Jin, M; Jung, HA; Sun, JM; Ahn, JS; Ahn, MJ; Choi, YL; Jeon, MJ; Kim, TY; Kim, WB; Kim, SW; Lee, DH; Jang, SJ; Kim, SW; Chung, JH; Kim, TH; Lee, SH
    View PubMed
  • EUR THYROID J 2024 10.1530/ETJ-23-0255 The association between BMI and BRAFV600E mutation may differ by primary tumor size Park, H; Heo, J; Ryu, HJ; Kim, MJ; Oh, YL; Kim, TH; Kim, SW; Chung, JH
    View PubMed
  • CANCER RES TREAT 2024 10.4143/crt.2023.1278 Combination of Dabrafenib and Trametinib in Patients with Metastatic BRAF V600E-Mutated Thyroid Cancer Jeon, Y; Park, S; Lee, SH; Kim, TH; Kim, SW; Ahn, MJ; Jung, HA; Chung, JH
    View PubMed
  • ENDOCRINOL METAB 2024 10.3803/EnM.2023.1896 Adequate Dose of Levothyroxine for Thyroid-Stimulating Hormone Suppression after Total Thyroidectomy in Patients with Differentiated Thyroid Cancer Ryu, HJ; Choi, MS; Park, H; Kim, TH; Chung, JH; Park, SY; Kim, SW
    View PubMed
  • SCI REP-UK 2024 10.1038/s41598-024-66096-9 The association between TSH and thyroid hormones in the normal or subclinical dysfunction range with left ventricular diastolic dysfunction Jun, JE; Kim, TH; Kim, SW; Chung, JH; Kim, JH; Lee, YB; Kang, MR
    View PubMed
  • ENDOCRINOL METAB 2024 10.3803/EnM.2023.1863 Clinical Manifestations of Malignant Struma Ovarii: A Retrospective Case Series in a Tertiary Hospital in Korea Ryu, HJ; Leem, D; Yoo, JH; Kim, TH; Kim, SW; Chung, JH
    View PubMed
  • PLOS ONE 2023 10.1371/journal.pone.0294145 Age-associated mortality is partially mediated by TERT promoter mutation status in differentiated thyroid carcinoma Heo, J; Lee, S; Park, J; Yang, HR; Park, H; Ki, CS; Oh, YL; Kim, HI; Kim, SW; Chung, JH; Kim, K; Kim, TH
    View PubMed
  • ENDOCRINE 2023 10.1007/s12020-023-03510-8 Mortality rate and causes of death in papillary thyroid microcarcinoma Heo, J; Ryu, HJ; Park, H; Kim, TH; Kim, SW; Oh, YL; Chung, JH
    View PubMed
  • SCI REP-UK 2023 10.1038/s41598-023-42907-3 Preoperative identification of low-risk medullary thyroid carcinoma: potential application to reduce total thyroidectomy Park, H; Ryu, HJ; Heo, J; Chung, MK; Son, YI; Kim, JH; Hahn, SY; Shin, JH; Oh, YL; Kim, SW; Chung, JH; Kim, JS; Kim, TH
    View PubMed
  • SCI REP-UK 2023 10.1038/s41598-023-29071-4 Association between urinary iodine concentration and the risk of papillary thyroid cancer by sex and age: a case-control study Hwang, Y; Oh, HK; Chung, JH; Kim, SW; Kim, JH; Kim, JS; Shin, MH
    View PubMed
  • ANN SURG ONCOL 2023 10.1245/s10434-022-13089-5 Selection Criteria for Completion Thyroidectomy in Follicular Thyroid Carcinoma Using Primary Tumor Size and TERT Promoter Mutational Status Park, H; Heo, J; Ki, CS; Shin, JH; Oh, YL; Son, YI; Kim, JS; Kim, SW; Chung, JH; Kim, TY; Kim, TH; Kim, JH
    View PubMed
  • THYROID 2023 10.1089/thy.2022.0216 Dyslipidemia Is a Risk Factor for Hypothyroidism in Women: A Longitudinal Cohort Study from South Korea Kim, HI; Kim, TH; Kim, H; Kim, SW; Hahm, JR; Chung, JH
    View PubMed
  • ANN SURG ONCOL 2023 10.1245/s10434-023-13146-7 ASO Visual Abstract: Selection Criteria for Completion Thyroidectomy in Follicular Thyroid Carcinoma Using Primary Tumor Size and TERT Promoter Mutational Status Park, H; Heo, J; Ki, CS; Shin, JH; Oh, YL; Son, YI; Kim, JS; Kim, SW; Chung, JH; Kim, TY; Kim, TH; Kim, JH
    View PubMed
  • ENDOCRINOL METAB 2022 10.3803/EnM.2022.601 Frequency of TERT Promoter Mutations in Real-World Analysis of 2,092 Thyroid Carcinoma Patients (Endocrinol Metab 2022;37:652-63, Heera Yang et al.) Park, H; Chung, JH
    View PubMed
  • ENDOCRINOL METAB 2022 10.3803/EnM.2022.1591 Identification of Mutations in the Thyroxine-Binding Globulin (TBG) Gene in Patients with TBG Deficiency in Korea Heo, J; Kim, SM; Ryu, HJ; Park, H; Kim, TH; Chung, JH; Park, HD; Kim, SW
    View PubMed
  • FRONT ENDOCRINOL 2022 10.3389/fendo.2022.1032764 Graves' disease, its treatments, and the risk of atrial fibrillation: A Korean population-based study Cho, YY; Kim, B; Choi, D; Kim, CH; Shin, DW; Kim, JS; Park, SJ; Kim, SW; Chung, JH; Han, K; Kim, TH
    View PubMed
  • EPILEPSIA 2022 10.1111/epi.17407 The longitudinal effect of oxcarbazepine on thyroid function in children and adolescents with epilepsy Park, H; Heo, J; Kim, MJ; Lee, JH; Kim, MS; Jin, DK; Kim, TH; Chung, JH; Cho, SY; Kim, SW
    View PubMed
  • ENDOCRINOL METAB 2022 10.3803/EnM.2022.1477 Frequency of TERT Promoter Mutations in Real-World Analysis of 2,092 Thyroid Carcinoma Patients Yang, HR; Park, H; Ryu, HJ; Heo, J; Kim, JS; Oh, YL; Choe, JH; Kim, JH; Kim, JS; Jang, HW; Kim, TH; Kim, SW; Chung, JH
    View PubMed
  • FRONT ENDOCRINOL 2022 10.3389/fendo.2022.906340 Editorial: The Legacy of Dr. Leonard D. Kohn to Thyroid Pathophysiology Giuliani, C; Shimura, H; Chung, JH; Napolitano, G
    View PubMed
  • ENDOCRINOL METAB 2022 10.3803/EnM.2022.1429 Bone Mineral Density Screening Interval and Transition to Osteoporosis in Asian Women Park, H; Yang, H; Heo, J; Jang, HW; Chung, JH; Kim, TH; Min, YK; Kim, SW
    View PubMed
  • ENDOCRINOL METAB 2022 10.3803/EnM.2021.1333 Graves' Disease and the Risk of End-Stage Renal Disease: A Korean Population-Based Study Cho, YY; Kim, B; Shin, DW; Jang, HR; Kim, BY; Jung, CH; Kim, JH; Kim, SW; Chung, JH; Han, K; Kim, TH
    View PubMed
  • CLIN ENDOCRINOL 2022 10.1111/cen.14698 Bone-density testing interval and transition to osteoporosis in differentiated thyroid carcinoma patients on TSH suppression therapy Park, H; Park, J; Yoo, H; Kim, S; Koh, JH; Jee, JH; Min, YK; Chung, JH; Kim, TH; Kang, M; Kim, SW
    View PubMed
  • ULTRASONOGRAPHY 2022 10.14366/usg.21200 What is the difference between the tall cell variant and the classic type of papillary thyroid carcinoma on ultrasonography? Kim, H; Oh, YL; Chung, JH; Hahn, SY; Park, KW; Kim, TH; Shin, JH
    View PubMed
  • CANCERS 2021 10.3390/cancers13122943 2021 Proposal of a New Prognostic Model for Differentiated Thyroid Cancer with TERT Promoter Mutations Park1, J; Lee, S; Park, J; Park, H; Ki, CS; Oh, YL; Shin, JH; Kim, JS; Kim, SW; Chung, JH; Kim, K; Kim, TH
    View PubMed
  • ENDOCRINOL METAB 2021 10.3803/EnM.2021.1070 2021 Antithyroid Drug Treatment in Graves' Disease Chung1, JH
    View PubMed
  • FRONT ENDOCRINOL (LAUSANNE) 2021 10.3389/fendo.2021.681148 2021 Trends in Childhood Thyroid Cancer incidence in Korea and Its Potential Risk Factors Park1, J; Park, H; Kim, TH; Kim, SW; Jang, HW; Chung, JH
    View PubMed
  • FRONT ENDOCRINOL (LAUSANNE) 2021 10.3389/fendo.2021.680647 2021 Risk of All-Cause Mortality in Levothyroxine-Treated Hypothyroid Patients: A Nationwide Korean Cohort Study Sohn1, SY; Seo, GH; Chung, JH
    View PubMed
  • CANCERS 2021 10.3390/cancers13081948 2021 Comparison of Four Ultrasonography-Based Risk Stratification Systems in Thyroid Nodules with Nondiagnostic/Unsatisfactory Cytology: A Real-World Study Lee1, YB; Oh, YL; Shin, JH; Kim, SW; Chung, JH; Min, YK; Hahn, SY; Kim, TH
    View PubMed
  • CANCERS 2021 10.3390/cancers13081913 2021 Prognostic Value of the Neutrophil-to-Lymphocyte Ratio before and after Radiotherapy for Anaplastic Thyroid Carcinoma Park1, J; Park, J; Shin, JH; Oh, YL; Jung, HA; Chung, MK; Choe, JH; Ahn, YC; Kim, SW; Chung, JH; Kim, TH; Noh, JM
    View PubMed
  • ENDOCRINE 2021 10.1007/s12020-021-02725-x 2021 The longer the antithyroid drug is used, the lower the relapse rate in Graves' disease: a retrospective multicenter cohort study in Korea Park1, SY; Kim, BH; Kim, M; Hong, AR; Park, J; Park, H; Choi, MS; Kim, TH; Kim, SW; Kang, HC; Chung, JH
    View PubMed
  • CANCERS 2021 10.3390/cancers13040648 2021 TERT Promoter Mutations and the 8th Edition TNM Classification in Predicting the Survival of Thyroid Cancer Patients Park1, J; Lee, S; Kim, K; Park, H; Ki, CS; Oh, YL; Shin, JH; Kim, JS; Kim, SW; Chung, JH; Kim, TH
    View PubMed
  • SCI REP-UK 2021 10.1038/s41598-021-01898-9 Pattern analysis for prognosis of differentiated thyroid cancer according to preoperative serum thyrotropin levels Kim, H; Jung, J; Cho, YS; Choi, JY; Park, H; You-Bin Lee; Kim, SW; Chung, JH; Kim, TH
    View PubMed
  • CANCERS 2021 10.3390/cancers13225842 Metastatic Lymph Node Ratio for Predicting Recurrence in Medullary Thyroid Cancer Kim, J; Park, J; Park, H; Choi, MS; Jang, HW; Kim, TH; Kim, SW; Chung, JH
    View PubMed
  • FRONT ENDOCRINOL 2021 10.3389/fendo.2021.749973 Prognostic Value of Preoperative Serum Calcitonin Levels for Predicting the Recurrence of Medullary Thyroid Carcinoma Park, H; Park, SY; Park, J; Choe, JH; Chung, MK; Woo, SY; Choi, JY; Kim, SW; Chung, JH; Kim, TH
    View PubMed
  • MODERN PATHOL 2021 10.1038/s41379-021-00907-6 Molecular classification of follicular thyroid carcinoma based on TERT promoter mutations Park, H; Shin, HC; Yang, H; Heo, J; Ki, CS; Kim, HS; Kim, JH; Hahn, SY; Chung, YJ; Kim, SW; Chung, JH; Oh, YL; Kim, TH
    View PubMed
  • CANCERS 2021 10.3390/cancers13184670 Long-Term Outcomes and Causes of Death among Medullary Thyroid Carcinoma Patients with Distant Metastases Park, H; Yang, H; Heo, J; Kim, TH; Kim, SW; Chung, JH
    View PubMed
  • THYROID 2021 10.1089/thy.2021.0094 Tumor Volume Doubling Time in Active Surveillance of Papillary Thyroid Microcarcinoma: A Multicenter Cohort Study in Korea Jin, M; Kim, HI; Ha, J; Jeon, MJ; Kim, WG; Lim, DJ; Kim, TY; Chung, JH; Shong, YK; Kim, TH; Kim, WB
    View PubMed
  • THYROID 2021 10.1089/thy.2020.0756 Changes in Thyrotropin Receptor Antibody Levels Following Total Thyroidectomy or Radioiodine Therapy in Patients with Refractory Graves' Disease Kim, J; Choi, MS; Park, J; Park, H; Jang, HW; Choe, JH; Kim, JH; Kim, JS; Cho, YS; Choi, JY; Kim, TH; Chung, JH; Kim, SW
    View PubMed
  • ANN SURG ONCOL 2021 10.1245/s10434-021-10383-6 Surgeon Volume and Long-Term Oncologic Outcomes in Patients with Medullary Thyroid Carcinoma Park, H; Kim, HI; Choe, JH; Chung, MK; Son, YI; Hahn, SY; Hwang, NY; Woo, SY; Kim, SW; Chung, JH; Kim, TH; Kim, JS
    View PubMed
  • CANCERS 2020 10.3390/cancers12102894 2020 Preoperative Serum Calcitonin and Its Correlation with Extent of Lymph Node Metastasis in Medullary Thyroid Carcinoma Park1, H; Park, J; Choi, MS; Kim, J; Kim, H; Shin, JH; Kim, JH; Kim, JS; Kim, SW; Chung, JH; Kim, TH
    View PubMed
  • INT J MOL SCI 2020 10.3390/ijms21165629 2020 Highly Sensitive and Specific Molecular Test for Mutations in the Diagnosis of Thyroid Nodules A Prospective Study ofBRAF-Prevalent Population Cho1, YY; Park, SY; Shin, JH; Oh, YL; Choe, JH; Kim, JH; Kim, JS; Yim, HS; Kim, YL; Ki, CS; Kim, TH; Chung, JH; Kim, SW
    View PubMed
  • CANCERS 2020 10.3390/cancers12082323 2020 Clinical Course from Diagnosis to Death in Patients with Well-Differentiated Thyroid Cancer Park1, H; Park, J; Park, SY; Kim, TH; Kim, SW; Chung, JH
    View PubMed
  • NUCL MED COMMUN 2020 10.1097/MNM.0000000000001138 2020 The success rate of radioactive iodine therapy for Graves' disease in iodine-replete area and affecting factors: a single-center study Park1, H; Kim, HI; Park, J; Park, SY; Kim, TH; Chung, JH; Choi, JY; Kim, SW
    View PubMed
  • CANCERS 2020 10.3390/cancers12030625 2020 Preoperative Serum Thyroglobulin and Its Correlation with the Burden and Extent of Differentiated Thyroid Cancer Kim1, H; Park, SY; Choe, JH; Kim, JS; Hahn, SY; Kim, SW; Chung, JH; Jung, J; Kim, TH
    View PubMed
  • ENDOCRINOL METAB 2020 10.3803/EnM.2020.35.1.7 2020 Update on Thyroid Hormone Levels and Thyroid Dysfunction in the Korean Population Based on Data from the Korea National Health and Nutrition. Examination Survey VI (2013 to 2015) Chung1, JH
    View PubMed
  • CLIN ENDOCRINOL 2020 10.1111/cen.14167 2020 Ultrasound-guided fine-needle aspiration or core needle biopsy for diagnosing follicular thyroid carcinoma? Park1, KW; Shin, JH; Hahn, SY; Oh, YL; Kim, SW; Kim, TH; Chung, JH
    View PubMed
  • SCI REP-UK 2019 10.1038/s41598-019-55370-w 2019 Improved survival after early detection of asymptomatic distant metastasis in patients with thyroid cancer Kim1, H; Park, SY; Jung, J; Kim, JH; Hahn, SY; Shin, JH; Oh, YL; Chung, MK; Kim, HI; Kim, SW; Chung, JH; Kim, TH
    View PubMed
  • THYROID 2019 10.1089/thy.2019.0261 2019 Multifocality in a Patient with Cribriform-Morular Variant of Papillary Thyroid Carcinoma Is an Important Clue for the Diagnosis of Familial Adenomatous Polyposis Park1, J; Kim, JW; Park, H; Park, SY; Kim, TH; Kim, SW; Oh, YL; Chung, JH
    View PubMed
  • EUR J NUTR 2019 10.1007/s00394-018-1837-4 2019 Non-immune-related hypothyroidism and its relationship with excess iodine Kim1, HI; Oh, HK; Park, SY; Jang, HW; Shin, MH; Han, JM; Bae, JC; Kim, SW; Kim, TH; Chung, JH
    View PubMed
  • THYROID 2019 10.1089/thy.2019.0246 2019 Extended Real-World Observation of Patients Treated with Sorafenib for Radioactive Iodine-Refractory Differentiated Thyroid Carcinoma and Impact of Lenvatinib Salvage Treatment: A Korean Multicenter Study Oh1, HS; Shin, DY; Kim, M; Park, SY; Kim, TH; Kim, BH; Kim, EY; Kim, WB; Chung, JH; Shong, YK; Lim, DJ; Kim, WG
    View PubMed
  • BJU INT 2019 10.1111/bju.14902 2019 Effects of poloxamer-based thermo-sensitive sol-gel agent on urethral stricture after transurethral resection of the prostate for benign prostatic hyperplasia: a multicentre, single-blinded, randomised controlled trial Chung1, JH; Kim, KS; Choi, JD; Kim, TH; Lee, KS; Oh, CY; Noh, JH; Kim, JS; Kim, WT; Lee, SH; Kim, JH; Kim, TN; Huh, W; Lee, SW
    View PubMed
  • THYROID 2019 10.1089/thy.2018.0541 2019 Impact of Extranodal Extension on Risk Stratification in Papillary Thyroid Carcinoma Kim1, HI; Hyeon, J; Park, SY; Ahn, HS; Kim, K; Han, JM; Bae, JC; Shin, JH; Kim, JS; Kim, SW; Chung, JH; Kim, TH; Oh, YL
    View PubMed
  • INTERNATIONAL NEUROUROLOGY JOURNAL 2019 10.5213/inj.1938026.013 2019 Effect of Nocturnal Hypoxia on Nocturia in Patients With Obstructive Sleep Apnea Chung1, JH; Moon, HS; Park, SY; Kim, KR; Cho, SH; Kim, YT
    View PubMed
  • ENDOCRINE 2019 10.1007/s12020-018-1807-x 2019 Long-term outcomes of renal function after radioactive iodine therapy for thyroid cancer according to preparation method: thyroid hormone withdrawal vs. recombinant human thyrotropin Cho1, YY; Kim, SK; Jung, JH; Hahm, JR; Kim, TH; Chung, JH; Kim, SW
    View PubMed
  • EUR J NUTR 2019 10.1007/s00394-017-1587-8 2019 Urinary iodine concentration and thyroid hormones: Korea National Health and Nutrition Examination Survey 2013-2015 Kim1, HI; Oh, HK; Park, SY; Jang, HW; Shin, MH; Kim, SW; Kim, TH; Chung, JH
    View PubMed
  • ORAL ONCOL 2019 10.1016/j.oraloncology.2018.12.014 2019 Refining the tumor-node-metastasis staging system for individualized treatment of differentiated thyroid carcinoma Kim1, YN; Kim, M; Ahn, HS; Kim, K; Park, SY; Kim, HI; Jeon, MJ; Kim, WG; Kim, SW; Kim, WB; Chung, JH; Shong, YK; Kim, TY; Kim, TH
    View PubMed
  • THYROID 2018 10.1089/thy.2018.0263 2018 Active Surveillance of Low-Risk Papillary Thyroid Microcarcinoma: A Multi-Center Cohort Study in Korea Oh1, HS; Ha, J; Kim, HI; Kim, TH; Kim, WG; Lim, DJ; Kim, TY; Kim, SW; Kim, WB; Shong, YK; Chung, JH; Baek, JH
    View PubMed
  • ORAL ONCOL 2018 10.1016/j.oraloncology.2018.10.029 2018 Eighth edition of tumor-node-metastasis staging system improve survival predictability for papillary, but not follicular thyroid carcinoma: A multicenter cohort study Kim1, M; Kim, HI; Jeon, MJ; Kim, HK; Kim, EH; Yi, HS; Kim, ES; Kim, H; Kim, BH; Kim, TY; Kim, SW; Kang, HC; Kim, WB; Chung, JH; Shong, YK; Kim, TH; Kim, WG
    View PubMed
  • J CLIN ENDOCR METAB 2018 10.1210/jc.2018-01386 2018 Clinical Validation of the Prognostic Stage Groups of the Eighth-Edition TNM Staging for Medullary Thyroid Carcinoma Park1, SY; Cho, YY; Kim, HI; Choe, JH; Kim, JH; Kim, JS; Oh, YL; Hahn, SY; Shin, JH; Kim, K; Kim, SW; Chung, JH; Kim, TH
    View PubMed
  • ORAL ONCOL 2018 10.1016/j.oraloncology.2018.09.008 2018 Modification of the eight-edition tumor-node-metastasis staging system with N1b for papillary thyroid carcinoma: A multi-institutional cohort study Kim1, M; Kim, HK; Kim, HI; Kim, EH; Jeon, MJ; Yi, HS; Kim, ES; Kim, H; Kim, TH; Kim, BH; Kim, TY; Kang, HC; Kim, WB; Chung, JH; Shon, YK; Kim, SW; Kim, WG
    View PubMed
  • SCI REP-UK 2018 10.1038/s41598-018-31955-9 2018 Modified Bethesda system informing cytopathologic adequacy improves malignancy risk stratification in nodules considered benign or atypia(follicular lesion) of undetermined significance Lee1, YB; Kim, JY; Cho, H; Hahn, SY; Shin, JH; Lee, SE; Jun, JE; Kim, SW; Chung, JH; Kim, TH; Oh, YL
    View PubMed
  • ORAL ONCOL 2018 10.1016/j.oraloncology.2018.07.002 2018 Low versus high activity radioiodine remnant ablation for differentiated thyroid carcinoma with gross extrathyroidal extension invading only strap muscles Park1, SY; Kim, HI; Choi, JY; Choe, JH; Kim, JH; Kim, JS; Oh, YL; Hahn, SY; Shin, JH; Ahn, SH; Kim, K; Jeong, JG; Kim, SW; Chung, JH; Kim, TH
    View PubMed
  • BRIT J SURG 2018 10.1002/bjs.10830 2018 Prognostic significance of gross extrathyroidal extension invading only strap muscles in differentiated thyroid carcinoma Park1, SY; Kim, HI; Kim, JH; Kim, JS; Oh, YL; Kim, SW; Chung, JH; Jang, HW; Kim, TH
    View PubMed
  • THYROID 2018 10.1089/thy.2017.0550 2018 Protective Effect of Metformin Against Thyroid Cancer Development: A Population-Based Study in Korea Cho1, YY; Kang, MJ; Kim, SK; Jung, JH; Hahm, JR; Kim, TH; Nam, JY; Lee, BW; Lee, YH; Chung, JH; Song, SO; Kim, SW
    View PubMed
  • KOREAN JOURNAL OF INTERNAL MEDICINE 2018 10.3904/kjirn.2016.051 2018 Reference intervals of thyroid hormones during pregnancy in Korea, an iodine-replete area Kim1, HJ; Cho, YY; Kim, SW; Kim, TH; Jang, HW; Lee, SY; Choi, SJ; Roh, CR; Kim, JH; Chung, JH; Oh, SY
    View PubMed
  • HISTOPATHOLOGY 2018 10.1111/his.13401 2018 Molecular genotyping of the non-invasive encapsulated follicular variant of papillary thyroid carcinoma Kim1, TH; Lee, M; Kwon, AY; Choe, JH; Kim, JH; Kim, JS; Hahn, SY; Shin, JH; Chung, MK; Son, YI; Ki, CS; Yim, HS; Kim, YL; Chung, JH; Kim, SW; Oh, YL
    View PubMed
  • THYROID 2018 10.1089/thy.2017.0356 2018 Tertiary Care Experience of Sorafenib in the Treatment of Progressive Radioiodine-Refractory Differentiated Thyroid Carcinoma: A Korean Multicenter Study Kim1, M; Kim, TH; Shin, DY; Lim, DJ; Kim, EY; Kim, WB; Chung, JH; Shong, YK; Kim, BH; Kim, WG
    View PubMed
  • ANN INTERN MED 2018 10.7326/M17-1398 2018 Antithyroid Drugs and Congenital Malformations A Nationwide Korean Cohort Study Seo1, GH; Kim, TH; Chung, JH
    View PubMed
  • EUR J NUTR 2018 10.1007/s00394-016-1370-2 2018 Iodine intake as a risk factor for BRAF mutations in papillary thyroid cancer patients from an iodine-replete area Kim1, HJ; Park, HK; Byun, DW; Suh, K; Yoo, MH; Min, YK; Kim, SW; Chung, JH
    View PubMed
  • ORAL ONCOL 2018 10.1016/j.oraloncology.2018.01.021 2018 Refining the eighth edition AJCC TNM classification and prognostic groups for papillary thyroid cancer with lateral nodal metastasis Kim1, HI; Kim, K; Park, SY; Choe, JH; Kim, JH; Kim, JS; Oh, YL; Hahn, SY; Shin, JH; Ahn, HS; Kim, SW; Kim, TH; Chung, JH
    View PubMed
  • CLIN ENDOCRINOL 2018 10.1111/cen.13489 2018 Prognostic indicators of outcomes in patients with lung metastases from differentiated thyroid carcinoma during long-term follow-up Sohn1, SY; Kim, HI; Kim, YN; Kim, TH; Kim, W; Chung, JH
    View PubMed
  • BRIT J SURG 2018 10.1002/bjs.10655 2018 Surgeon volume and prognosis of patients with advanced papillary thyroid cancer and lateral nodal metastasis Kim1, HI; Kim, TH; Choe, JH; Kim, JH; Kim, JS; Kim, YN; Kim, H; Kim, SW; Chung, JH
    View PubMed
  • J CLIN ENDOCR METAB 2018 10.1210/jc.2017-01775 2018 High Serum TSH Level Is Associated With Progression of Papillary Thyroid Microcarcinoma During Active Surveillance Kim1, HI; Jang, HW; Ahn, HS; Ahn, S; Park, SY; Oh, YL; Hahn, SY; Shin, JH; Kim, JH; Kim, JS; Chung, JH; Kim, TH; Kim, SW
    View PubMed
  • PLoS One 2018 10.1371/journal.pone.0190738 2018 Age- and gender-specific reference intervals of TSH and free T4 in an iodine-replete area: Data from Korean National Health and Nutrition Examination Survey IV (2013-2015) Park1, SY; Kim, HI; Oh, HK; Kim, TH; Jang, HW; Chung, JH; Shin, MH; Kim, SW
    View PubMed
  • Oncoimmunology 2018 10.1080/2162402X.2017.1375642 2018 Development of thyroid dysfunction is associated with clinical response to PD-1 blockade treatment in patients with advanced non-small cell lung cancer Kim1, HI; Kim, M; Lee, SH; Park, SY; Kim, YN; Kim, H; Jeon, MJ; Kim, TY; Kim, SW; Kim, WB; Kim, SW; Lee, DH; Park, K; Ahn, MJ; Chung, JH; Shong, YK; Kim, WG; Kim, TH
    View PubMed
  • THYROID 2018 10.1089/thy.2017.0214 2018 Practical Initial Risk Stratification Based on Lymph Node Metastases in Pediatric and Adolescent Differentiated Thyroid Cancer Jeon1, MJ; Kim, YN; Sung, TY; Hong, SJ; Cho, YY; Kim, TY; Shong, YK; Kim, WB; Kim, SW; Chung, JH; Kim, TH; Kim, WG
    View PubMed
  • ONCOTARGET 2017 10.18632/oncotarget.22430 2017 Ultrasound and clinicopathological features of papillary thyroid carcinomas with BRAF and TERT promoter mutations Hahn1, SY; Kim, TH; Ki, CS; Kim, SW; Ahn, S; Shin, JH; Chung, JH
    View PubMed
  • SCI REP-UK 2017 10.1038/s41598-017-17176-6 2017 Preoperative serum thyroglobulin predicts initial distant metastasis in patients with differentiated thyroid cancer Kim1, H; Kim, YN; Kim, HI; Park, SY; Choe, JH; Kim, JH; Kim, JS; Chung, JH; Kim, TH; Kim, SW
    View PubMed
  • ENDOCRINE 2017 10.1007/s12020-017-1381-7 2017 Validation of dynamic risk stratification in pediatric differentiated thyroid cancer Sohn1, SY; Kim, YN; Kim, HI; Kim, TH; Kim, SW; Chung, JH
    View PubMed
  • Cancer Med 2017 10.1002/cam4.1160 2017 Restratification of survival prognosis of N1b papillary thyroid cancer by lateral lymph node ratio and largest lymph node size Kim1, HI; Kim, TH; Choe, JH; Kim, JH; Kim, JS; Oh, YL; Hahn, SY; Shin, JH; Jang, HW; Kim, YN; Kim, H; Ahn, HS; Kim, K; Kim, SW; Chung, JH
    View PubMed
  • ENDOCRINE 2017 10.1007/s12020-017-1363-9 2017 Hormetic effect of triiodothyronine in metabolically healthy obese persons Jun1, JE; Kim, TH; Lee, SE; Lee, YB; Jee, JH; Bae, JC; Jin, SM; Hur, KY; Kim, JH; Kim, SW; Chung, JH; Min, YK; Lee, MK
    View PubMed
  • CLIN ENDOCRINOL 2017 10.1111/cen.13344 2017 Delayed TSH recovery after dose adjustment during TSH-suppressive levothyroxine therapy of thyroid cancer Kim1, HI; Kim, TH; Kim, H; Kim, YN; Jang, HW; Kim, JH; Hur, KY; Chung, JH; Kim, SW
    View PubMed
  • ORAL ONCOL 2017 10.1016/j.oraloncology.2017.06.004 2017 Prognostic value of the eighth edition AJCC TNM classification for differentiated thyroid carcinoma Kim1, TH; Kim, YN; Kim, HI; Park, SY; Choe, JH; Kim, JH; Kim, JS; Oh, YL; Hahn, SY; Shin, JH; Kim, K; Jeong, JG; Kim, SW; Chung, JH
    View PubMed
  • ENDOCRINE 2017 10.1007/s12020-017-1340-3 2017 Ultrasonographic prediction of highly aggressive telomerase reverse transcriptase (TERT) promoter-mutated papillary thyroid cancer Kim1, TH; Ki, CS; Hahn, SY; Oh, YL; Jang, HW; Kim, SW; Chung, JH; Shin, JH
    View PubMed
  • PLoS One 2017 10.1371/journal.pone.0182090 2017 Subclinical thyroid dysfunction and risk of carotid atherosclerosis Kim1, H; Kim, TH; Kim, HI; Park, SY; Kim, YN; Kim, S; Kim, MJ; Jin, SM; Hur, KY; Kim, JH; Lee, MK; Min, YK; Chung, JH; Kang, M; Kim, SW
    View PubMed
  • THYROID 2017 10.1089/thy.2016.0648 2017 Patterns of Initial Recurrence in Completely Resected Papillary Thyroid Carcinoma Kim1, H; Kim, TH; Choe, JH; Kim, JH; Kim, JS; Oh, YL; Hahn, SY; Shin, JH; Chi, SA; Jung, SH; Kim, YN; Kim, HI; Kim, SW; Chung, JH
    View PubMed
  • Osteoporos Int. 2017 Apr;28(4):1377-1384. doi: 10.1007/s00198-016-3892-0. Epub 2017 Feb 10. 2017 Serum 25-hydroxyvitamin D cutoffs for functional bone measures in postmenopausal osteoporosis Lee DY11,2, Jee JH3, Cho YY1, Jang JY1, Yu TY1, Kim TH1, Hong YJ1, Hong WJ1, Jin SM1, Hur KY1, Kim JH1, Kim SW1, Chung JH1, Lee MK1, Min YK4.
    View PubMed
  • Eur J Endocrinol. 2017 Apr;176(4):441-450. doi: 10.1530/EJE-16-0734. Epub 2017 Jan 18. 2017 Association of triiodothyronine levels with future development of metabolic syndrome in euthyroid middle-aged subjects: a 6-year retrospective longitudinal study Kim HJ11, Bae JC2, Park HK1, Byun DW1, Suh K1, Yoo MH1, Jae Hwan J3, Kim JH4, Min YK4, Kim SW4, Chung JH5.
    View PubMed
  • Eur J Nutr. 2017 Apr;56(3):965-971. doi: 10.1007/s00394-015-1144-2. Epub 2016 Jan 8. 2017 Strong association of relatively low and extremely excessive iodine intakes with thyroid cancer in an iodine-replete area Kim HJ11, Kim NK2, Park HK1, Byun DW1, Suh K1, Yoo MH1, Min YK2, Kim SW2, Chung JH3.
    View PubMed
  • Clin Endocrinol (Oxf). 2017 Mar;86(3):438-443. doi: 10.1111/cen.13254. Epub 2016 Nov 2. 2017 Optimal cut-off age in the TNM Staging system of differentiated thyroid cancer: is 55 years better than 45 years? Kim M11, Kim YN2, Kim WG1, Park S1, Kwon H1, Jeon MJ1, Ahn HS3, Jung SH4, Kim SW2, Kim WB1, Chung JH2, Shong YK1, Kim TH2, Kim TY1.
    View PubMed
  • J Clin Endocrinol Metab. 2017 Feb 1;102(2):625-633. doi: 10.1210/jc.2016-2287. 2017 Long-Term Recurrence of Small Papillary Thyroid Cancer and Its Risk Factors in a Korean Multicenter Study Hwangbo Y11,2, Kim JM3, Park YJ2, Lee EK1, Lee YJ1, Park DJ2, Choi YS4, Lee KD5, Sohn SY6, Kim SW6, Chung JH6, Lim DJ7, Kim MH7, Kim MJ3, Jo YS8, Shong MH8, Koong SS9, Hahm JR10, Jung JH10, Yi KH2,11.
    View PubMed
  • Head Neck. 2017 Feb;39(2):269-274. doi: 10.1002/hed.24578. Epub 2016 Sep 12. 2017 Current status and diagnostic values of the Bethesda system for reporting thyroid cytopathology in a papillary thyroid carcinoma-prevalent area Lee YB11, Cho YY2, Jang JY3, Kim TH1, Jang HW4, Chung JH1, Oh YL5, Kim SW1.
    View PubMed
  • Endocr Relat Cancer. 2017 Feb;24(2):97-106. doi: 10.1530/ERC-16-0421. 2017 Comprehensive screening for PD-L1 expression in thyroid cancer Ahn S11, Kim TH2, Kim SW2, Ki CS3, Jang HW4, Kim JS5, Kim JH5, Choe JH5, Shin JH6, Hahn SY6, Oh YL7, Chung JH8.
    View PubMed
  • Endocrine. 2017 Feb;55(2):503-512. doi: 10.1007/s12020-016-1138-8. Epub 2016 Oct 5. 2017 The effect of TSH change per year on the risk of incident chronic kidney disease in euthyroid subjects Lee DY11,2, Jee JH3, Jun JE1, Kim TH1, Jin SM1, Hur KY1, Kim SW1, Chung JH1, Lee MK1, Kim JH4,5.
    View PubMed
  • Ann Lab Med. 2017 Jan;37(1):63-65. doi: 10.3343/alm.2017.37.1.63. 2017 First Report of Familial Dysalbuminemic Hyperthyroxinemia With an ALB Variant Cho YY11,2, Song JS3, Park HD3, Kim YN1, Kim HI1, Kim TH1, Chung JH1, Ki CS4, Kim SW5.
    View PubMed
  • PLoS One. 2017 Jan 12;12(1):e0169775. doi: 10.1371/journal.pone.0169775. eCollection 2017. 2017 Effect of Rifampin on Thyroid Function Test in Patients on Levothyroxine Medication Kim HI11, Kim TH1, Kim H1, Kim YN1, Jang HW2, Chung JH1, Moon SM3, Jhun BW3, Lee H3, Koh WJ3, Kim SW1.
    View PubMed
  • Nutrients. 2016 Dec 8;8(12). pii: E797. 2016 A Prospective Study on Serum Methylmalonic Acid and Homocysteine in Pregnant Women Choi R11, Choi S2, Lim Y3, Cho YY4, Kim HJ5, Kim SW6, Chung JH7, Oh SY8, Lee SY9.
    View PubMed
  • Nutrients. 2016 Nov 23;8(11). pii: E749. 2016 A Prospective Study of Serum Trace Elements in Healthy Korean Pregnant Women Choi R11, Sun J2, Yoo H3, Kim S4, Cho YY5, Kim HJ6, Kim SW7, Chung JH8, Oh SY9, Lee SY10,11.
    View PubMed
  • Endocr Relat Cancer. 2016 Oct;23(10):813-23. doi: 10.1530/ERC-16-0219. Epub 2016 Aug 15. 2016 TERT promoter mutations and long-term survival in patients with thyroid cancer Kim TH11, Kim YE2, Ahn S3, Kim JY4, Ki CS5, Oh YL3, Kim K6, Yun JW7, Park WY7, Choe JH8, Kim JH8, Kim JS8, Kim SW1, Chung JH9.
    View PubMed
  • Head Neck. 2016 Oct;38(10):1501-8. doi: 10.1002/hed.24469. Epub 2016 Apr 7. 2016 Clinical outcomes of patients with hypercalcitoninemia after initial treatment for medullary thyroid cancer and postoperative serum calcitonin cutoffs for predicting structural recurrence Cho YY11, Jang HW2, Jang JY1, Kim TH1, Choe JH3, Kim JH3, Kim JS3, Kim SW1, Chung JH4.
    View PubMed
  • Ann Lab Med. 2016 Sep;36(5):413-9. doi: 10.3343/alm.2016.36.5.413. 2016 Performance Evaluation of the Serum Thyroglobulin Assays With Immunochemiluminometric Assay and Immunoradiometric Assay for Differentiated Thyroid Cancer Cho YY11, Chun S2, Lee SY2, Chung JH1, Park HD3, Kim SW4.
    View PubMed
  • Am J Clin Oncol. 2016 Aug;39(4):374-8. doi: 10.1097/COC.0000000000000072. 2016 Efficacy of Low-dose and High-dose Radioactive Iodine Ablation With rhTSH in Korean Patients With Differentiated Thyroid Carcinoma The First Report in Nonwestern Countries Joung JY11, Choi JH, Cho YY, Kim NK, Sohn SY, Kim SW, Chung JH.
    View PubMed
  • Thyroid. 2016 May;26(5):672-82. doi: 10.1089/thy.2015.0527. 2016 Highly Concordant Key Genetic Alterations in Primary Tumors and Matched Distant Metastases in Differentiated Thyroid Cancer Sohn SY11, Park WY2,3, Shin HT2, Bae JS2, Ki CS4, Oh YL5, Kim SW6, Chung JH6.
    View PubMed
  • Cancer Med. 2016 May;5(5):769-77. doi: 10.1002/cam4.636. Epub 2016 Jan 18. 2016 Triage of patients with AUS/FLUS on thyroid cytopathology: effectiveness of the multimodal diagnostic techniques Kim TH11, Jeong DJ1, Hahn SY2, Shin JH2, Oh YL3, Ki CS4, Kim JW4, Jang JY1, Cho YY1, Chung JH1, Kim SW1.
    View PubMed
  • Eur J Nutr. 2016 Mar;55(2):469-75. doi: 10.1007/s00394-015-0864-7. Epub 2015 Mar 7. 2016 Iodine status in healthy pregnant women in Korea: a first report Cho YY11, Kim HJ1,2, Oh SY3, Choi SJ3, Lee SY4, Joung JY1, Jeong DJ1, Sohn SY1, Chung JH1, Roh CR5, Kim SW6.
    View PubMed
  • Head Neck. 2016 Jan;38(1):159. doi: 10.1002/hed.24208. Epub 2015 Sep 8. 2016 Reply to Letter to the Editor regarding association of vascular invasion with increased mortality in patients with minimally invasive follicular thyroid carcinoma but not widely invasive follicular thyroid carcinoma Kim HJ11, Chung JH2.
    View PubMed
  • PLoS One. 2015 Dec 17;10(12):e0145292. doi: 10.1371/journal.pone.0145292. eCollection 2015. 2015 A Modest Protective Effect of Thyrotropin against Bone Loss Is Associated with Plasma Triiodothyronine Levels Kim TH11, Joung JY1, Kang M2, Choi SK3, Kim K3, Jang JY1, Cho YY1, Min YK1, Chung JH1, Kim SW1.
    View PubMed
  • PLoS One. 2015 Dec 17;10(12):e0145292. doi: 10.1371/journal.pone.0145292. eCollection 2015. 2015 A Modest Protective Effect of Thyrotropin against Bone Loss Is Associated with Plasma Triiodothyronine Levels Kim TH11, Joung JY1, Kang M2, Choi SK3, Kim K3, Jang JY1, Cho YY1, Min YK1, Chung JH1, Kim SW1.
    View PubMed
  • Thyroid. 2015 Aug;25(8):927-34. doi: 10.1089/thy.2014.0557. Epub 2015 Jul 2. 2015 Increased Risk of Leukemia After Radioactive Iodine Therapy in Patients with Thyroid Cancer: A Nationwide, Population-Based Study in Korea Seo GH11, Cho YY2, Chung JH2, Kim SW2.
    View PubMed
  • Head Neck. 2015 May;37(5):650-4. doi: 10.1002/hed.23650. Epub 2014 Apr 10. 2015 Number of tumor foci as predictor of lateral lymph node metastasis in papillary thyroid carcinoma Kim HJ11, Park HK, Byun DW, Suh K, Yoo MH, Min YK, Kim SW, Chung JH.
    View PubMed
  • Nutrients. 2015 May 11;7(5):3427-48. doi: 10.3390/nu7053427. 2015 High Prevalence of Vitamin D Deficiency in Pregnant Korean Women: The First Trimester and the Winter Season as Risk Factors for Vitamin D Deficiency Choi R11, Kim S2, Yoo H3, Cho YY4, Kim SW5, Chung JH6, Oh SY7, Lee SY8.
    View PubMed
  • Endocr J. 2015;62(3):243-50. doi: 10.1507/endocrj.EJ14-0384. Epub 2014 Dec 4. 2015 Diagnostic accuracy of plasma free metanephrines in a seated position compared with 24-hour urinary metanephrines in the investigation of pheochromocytoma Kim HJ11, Lee JI, Cho YY, Lee SY, Kim JH, Jung BC, Kim SW, Chung JH, Min YK, Lee MS, Lee MK, Kim JH.
    View PubMed
  • Eur J Clin Nutr. 2015 Mar;69(3):361-6. doi: 10.1038/ejcn.2014.284. Epub 2015 Feb 4. 2015 Effect of high dietary sodium on bone turnover markers and urinary calcium excretion in Korean postmenopausal women with low bone mass Park SM11, Joung JY1, Cho YY1, Sohn SY1, Hur KY1, Kim JH1, Kim SW1, Chung JH1, Lee MK1, Min YK1.
    View PubMed
  • Cancer. 2015 Jan 15;121(2):259-68. doi: 10.1002/cncr.29025. Epub 2014 Sep 15. 2015 Elevated Risks of Subsequent Primary Malignancies in Patients With Thyroid Cancer: A Nationwide, Population-Based Study in Korea Cho YY11, Lim J, Oh CM, Ryu J, Jung KW, Chung JH, Won YJ, Kim SW.
    View PubMed
  • Head Neck. 2014 Dec;36(12):1695-700. doi: 10.1002/hed.23511. Epub 2014 Feb 27. 2014 Association of vascular invasion with increased mortality in patients with minimally invasive follicular thyroid carcinoma but not widely invasive follicular thyroid carcinoma Kim HJ11, Sung JY, Oh YL, Kim JH, Son YI, Min YK, Kim SW, Chung JH.
    View PubMed
  • Thyroid. 2014 Sep;24(9):1361-8. doi: 10.1089/thy.2014.0046. Epub 2014 Jun 30. 2014 Effect of Iodine Restriction on Thyroid Function in Subclinical Hypothyroid Patients in an Iodine-Replete Area: A Long Period Observation in a Large-Scale Cohort Joung JY11, Cho YY, Park SM, Kim TH, Kim NK, Sohn SY, Kim SW, Chung JH.
    View PubMed
  • J Korean Med Sci. 2014 Aug;29(8):1033-4. doi: 10.3346/jkms.2014.29.8.1033. 2014 Unfounded Reports on Thyroid Cancer 1,Chung JH1.
    View PubMed
  • Clin Chem Lab Med. 2014 Jul;52(7):e139-42. doi: 10.1515/cclm-2013-1007. 2014 Evaluation of mutation profiling by matrix-assisted laser desorption ionization time-of-flight (MALDI-TOF) mass spectrometry in fine needle aspirations from papillary thyroid cancer Woo HI1, Kim SW, Ki CS, Shin JH, Oh YL, Kim JW, Chung JH.
    View PubMed
  • Asian Pac J Cancer Prev. 2014;15(12):5107-10. 2014 Effectiveness of Ultrasonographic Screening for Thyroid Cancer: Round-table Conference in the National Evidence-based Healthcare Collaborating Agency (NECA) in conjunction with the Korean Thyroid Association Shin S11, Park SE, Kim SY, Hyun MK, Kim SW, Kwon JW, Kim Y, Kim WB, Na DG, Park HA, Sheen SS, Yi KH, Chang HS, Cho JJ, Chung JH.
    View PubMed
  • Thyroid. 2014 May;24(5):872-7. doi: 10.1089/thy.2013.0238. Epub 2014 Mar 6. 2014 The Impact of Iodinated Contrast Agent Administered During Preoperative Computed Tomography Scan on Body Iodine Pool in Patients with Differentiated Thyroid Cancer Preparing for Radioactive Iodine Treatment Sohn SY11, Choi JH, Kim NK, Joung JY, Cho YY, Park SM, Kim TH, Jin SM, Bae JC, Lee SY, Chung JH, Kim SW.
    View PubMed
  • Endocrine. 2014 Mar;45(2):256-62. doi: 10.1007/s12020-013-9997-8. Epub 2013 Jul 3. 2014 Role of autophagy in the resistance to tumour necrosis factor-related apoptosis-inducing ligand-induced apoptosis in papillary and anaplastic thyroid cancer cells Jin SM11, Jang HW, Sohn SY, Kim NK, Joung JY, Cho YY, Kim SW, Chung JH.
    View PubMed
  • Head Neck. 2014 Jan;36(1):43-6. doi: 10.1002/hed.23252. Epub 2013 Jun 1. 2014 Lack of association between high serum thyroid-stimulating hormone level and risk of papillary thyroid microcarcinomas Sohn SY11, Kim HJ, Jang HW, Kim SW, Chung JH.
    View PubMed
  • J Diabetes Investig. 2014 Feb 12;5(1):51-9. doi: 10.1111/jdi.12127. Epub 2013 Sep 2. 2014 Predictive factors of durability to sitagliptin: Slower reduction of glycated hemoglobin, older age and higher baseline glycated hemoglobin Chung HS11, Suh S2, Kim MY3, Kim SK3, Kim HK3, Lee JI3, Hur KY3, Kim JH3, Min YK3, Lee MS3, Kim KW3, Kim SW3, Chung JH3, Lee MK3.
    View PubMed
  • World J Surg. 2013 Dec;37(12):2845-52. doi: 10.1007/s00268-013-2213-4. 2013 Prognostic Implications of Radioiodine Avidity and Serum Thyroglobulin in Differentiated Thyroid Carcinoma with Distant Metastasis Kim HJ11, Lee JI, Kim NK, Min YK, Kim SW, Chung JH.
    View PubMed
  • Head Neck. 2013 Apr;35(4):548-53. doi: 10.1002/hed.22997. Epub 2012 Apr 7. 2013 BRAF(V600E) mutation in fine-needle aspiration aspirates: Association with poorer prognostic factors in larger papillary thyroid carcinomas Lee JI11, Jang HW, Kim SW, Kim JW, Oh YL, Chung JH.
    View PubMed
  • Endocr Res. 2013;38(2):89-97. doi: 10.3109/07435800.2012.723292. 2013 ERK Phosphorylation Is Not Increased in Papillary Thyroid Carcinomas with BRAF(V600E) Mutation Compared to That of Corresponding Normal Thyroid Tissues Kim SW11, Kim HK, Lee JI, Jang HW, Choe JH, Kim JH, Kim JS, Hur KY, Kim JH, Chung JH.
    View PubMed
  • World J Surg. 2013 Feb;37(2):376-84. doi: 10.1007/s00268-012-1835-2. 2013 Multifocality, But Not Bilaterality, Is a Predictor of Disease Recurrence/Persistence of Papillary Thyroid Carcinoma Kim HJ11, Sohn SY, Jang HW, Kim SW, Chung JH.
    View PubMed
  • Clin Endocrinol (Oxf). 2012 Sep;77(3):459-64. doi: 10.1111/j.1365-2265.2012.04396.x. 2012 Time trend in tumour size and characteristics of anaplastic thyroid carcinoma Han JM11, Bae Kim W, Kim TY, Ryu JS, Gong G, Hong SJ, Kim JH, Oh YL, Jang HW, Kim SW, Chung JH, Shong YK.
    View PubMed
  • J Clin Endocrinol Metab. 2012 Jul;97(7):2299-306. doi: 10.1210/jc.2011-3135. Epub 2012 Apr 12. 2012 Clinical Implication of Highly Sensitive Detection of the BRAF V600E Mutation in Fine-Needle Aspirations of Thyroid Nodules: A Comparative Analysis of Three Molecular Assays in 4585 Consecutive Cases in a BRAF V600E Mutation-Prevalent Area Lee ST11, Kim SW, Ki CS, Jang JH, Shin JH, Oh YL, Kim JW, Chung JH.
    View PubMed
  • Head Neck. 2012 Apr;34(4):599-603. doi: 10.1002/hed.21575. Epub 2010 Nov 12. 2012 Characteristics of Killian-Jamieson diverticula mimicking a thyroid nodule Kim HK11, Lee JI, Jang HW, Bae SY, Lee JH, Kim YS, Shin JH, Kim SW, Chung JH.
    View PubMed
  • J Korean Med Sci. 2012 Feb;27(2):177-83. doi: 10.3346/jkms.2012.27.2.177. Epub 2012 Jan 27. 2012 The Ability of beta-Cells to Compensate for Insulin Resistance is Restored with a Reduction in Excess Growth Hormone in Korean Acromegalic Patients Kim SK11, Suh S, Lee JI, Hur KY, Chung JH, Lee MK, Min YK, Kim JH, Kim JH, Kim KW.
    View PubMed
  • Endocr Res. 2011;36(4):149-57. doi: 10.3109/07435800.2011.593012. 2011 Anti-proliferative Effect and Action Mechanism of Dexamethasone in Human Medullary Thyroid Cancer Cell Line Chung YJ11, Lee JI, Chong S, Seok JW, Park SJ, Jang HW, Kim SW, Chung JH.
    View PubMed
  • Immunol Invest. 2011;40(2):172-82. doi: 10.3109/08820139.2010.525571. Epub 2010 Nov 10. 2011 Identification of HLA-DRB1 Alleles Associated with Graves' Disease in Koreans by Sequence-Based Typing Jang HW11, Shin HW, Cho HJ, Kim HK, Lee JI, Kim SW, Kim JW, Chung JH.
    View PubMed
  • Endocr J. 2010;57(12):1045-54. Epub 2010 Oct 22. 2010 Localization of medullary thyroid carcinoma after surgery using (HC)-H-11-methionine PET/CT: comparison with F-18-FDG PET/CT Jang HW11, Choi JY, Lee JI, Kim HK, Shin HW, Shin JH, Kim SW, Chung JH.
    View PubMed
  • J Histochem Cytochem. 2010 Aug;58(8):731-40. doi: 10.1369/jhc.2010.955906. Epub 2010 Apr 26. 2010 Pathologic Changes and Glucose Homeostasis According to Expression of Human Islet Amyloid Polypeptide in Type 2 Diabetic Patients Park JY11, No HS, Ahn YR, Oh SH, Kim YS, Kim SY, Jang KT, Kim SW, Chung JH, Min YK, Heo JS, Choi SH, Choi DW, Lee MS, Lee MK, Kim JH, Kim KW.
    View PubMed
  • J Clin Endocrinol Metab. 2010 Aug;95(8):3693-700. doi: 10.1210/jc.2009-2795. Epub 2010 May 25. 2010 BRAF(V600E) Mutation Analysis in Fine-Needle Aspiration Cytology Specimens for Evaluation of Thyroid Nodule: A Large Series in a BRAF(V600E)-Prevalent Population Kim SW11, Lee JI, Kim JW, Ki CS, Oh YL, Choi YL, Shin JH, Kim HK, Jang HW, Chung JH.
    View PubMed
  • J Korean Med Sci. 2010 Feb;25(2):317-20. doi: 10.3346/jkms.2010.25.2.317. Epub 2010 Jan 19. 2010 Autosomal Dominant Hypocalcemia Caused by an Activating Mutation of the Calcium-Sensing Receptor Gene: The First Case Report in Korea Kim MY11, Tan AH, Ki CS, Lee JI, Jang HW, Shin HW, Kim SW, Min YK, Lee MS, Lee MK, Kim KW, Chung JH.
    View PubMed
  • Endocr J. 2009;56(3):399-405. Epub 2009 Feb 18. 2009 Clinical Characteristics of Primary Thyroid Lymphoma in Koreans Hwang YC11, Kim TY, Kim WB, Shong YK, Yi KH, Shong M, Jo YS, Kim WS, Chung JH.
    View PubMed
  • J Korean Med Sci. 2009 Feb;24(1):46-51. doi: 10.3346/jkms.2009.24.1.46. Epub 2009 Feb 28. 2009 Comparisons between Macroadenomas and Microadenomas in Cushing's Disease: Characteristics of Hormone Secretion and Clinical Outcomes Hwang YC11, Chung JH, Min YK, Lee MS, Lee MK, Kim KW.
    View PubMed
  • J Korean Med Sci. 2008 Oct;23(5):870-6. doi: 10.3346/jkms.2008.23.5.870. 2008 Overexpression of USF Increases TGF-beta 1 Protein Levels, But G1 Phase Arrest was not Induced in FRTL-5 Cells Kim KS11, Jung HS, Chung YJ, Jung TS, Jang HW, Lee MS, Kim KW, Chung JH.
    View PubMed
  • J Korean Med Sci. 2008 Apr;23(2):193-8. doi: 10.3346/jkms.2008.23.2.193. 2008 The associations of total and differential white blood cell counts with obesity, hypertension, dyslipidemia and glucose intolerance in a Korean population Kim DJ11, Noh JH, Lee BW, Choi YH, Chung JH, Min YK, Lee MS, Lee MK, Kim KW.
    View PubMed
  • Head Neck. 2007 Aug;29(8):765-72. 2007 Prognostic factors for Korean patients with anaplastic thyroid carcinoma Kim TY11, Kim KW, Jung TS, Kim JM, Kim SW, Chung KW, Kim EY, Gong G, Oh YL, Cho SY, Yi KH, Kim WB, Park do J, Chung JH, Cho BY, Shong YK.
    View PubMed
  • Endocr J. 2007 Apr;54(2):275-85. Epub 2007 Mar 20. 2007 USF inhibits cell proliferation through delay in G2/M phase in FRTL-5 cells Jung HS11, Kim KS, Chung YJ, Chung HK, Min YK, Lee MS, Lee MK, Kim KW, Chung JH.
    View PubMed
  • Endocr J. 2007 Apr;54(2):265-74. Epub 2007 Mar 20. 2007 Clinical features and prognostic factors for survival in patients with poorly differentiated thyroid carcinoma and comparison to the patients with the aggressive variants of papillary thyroid carcinoma Jung TS11, Kim TY, Kim KW, Oh YL, Park do J, Cho BY, Shong YK, Kim WB, Park YJ, Jung JH, Chung JH.
    View PubMed
  • Thyroid. 2006 Dec;16(12):1251-7. 2006 Continued suppression of serum TSH level may be attributed to TSH receptor antibody activity as well as the severity of thyrotoxicosis and the time to recovery of thyroid hormone in treated euthyroid Graves' patients Chung YJ11, Lee BW, Kim JY, Jung JH, Min YK, Lee MS, Lee MK, Kim KW, Chung JH.
    View PubMed
  • Thyroid. 2006 Jun;16(6):609-14. 2006 A rare extracellular D631Y germline mutation of the RET proto-oncogene in two Korean families with multiple endocrine neoplasia 2A Bae SJ11, Kim DJ, Kim JY, Park SY, Choi SH, Song YD, Ki CS, Chung JH.
    View PubMed
  • Thyroid. 2006 May;16(5):461-9. 2006 Well-differentiated epithelial thyroid cancer management in the Asia Pacific region: A report and clinical practice guideline Sundram F11, Robinson BG, Kung A, Lim-Abrahan MA, Bay NQ, Chuan LK, Chung JH, Huang SM, Hsu LC, Kamaruddin N, Cheah WK, Kim WB, Koong SS, Lin HD, Mangklabruks A, Paz-Pacheco E, Rauff A, Ladenson PW.
    View PubMed
  • Metabolism. 2006 Jan;55(1):135-41. 2006 Insulin secretory defect plays a major role in the development of diabetes in patients with distal pancreatectomy Lee BW11, Kang HW, Heo JS, Choi SH, Kim SY, Min YK, Chung JH, Lee MK, Lee MS, Kim KW.
    View PubMed
  • Exp Mol Med. 2005 Dec 31;37(6):513-23. 2005 Effective glycemic control achieved by transplanting non-viral cationic liposome-mediated VEGF-transfected islets in streptozotocin-induced diabetic mice Chae HY11, Lee BW, Oh SH, Ahn YR, Chung JH, Min YK, Lee MS, Lee MK, Kim KW.
    View PubMed
  • Diabetes Res Clin Pract. 2005 Oct;70(1):38-45. Epub 2005 Apr 18. 2005 Heterogeneity of early-onset and ketosis-resistant diabetes in Korean subjects - is it possible to determine cut-off age of early-onset type 2 diabetes Lee BW11, Kim SY, Kim JY, Cho KY, Chung YJ, Min YK, Chung JH, Lee MK, Lee MS, Kim KW.
    View PubMed
  • J Korean Med Sci. 2005 Aug;20(4):562-5. 2005 Fasting plasma glucose cutoff value for the prediction of future diabetes development: A study of middle-aged Koreans in a health promotion center Kim DJ11, Cho NH, Noh JH, Kim HJ, Choi YH, Jung JH, Min YK, Lee MS, Lee MK, Kim KW.
    View PubMed
  • Transplantation. 2005 Jun 15;79(11):1568-74. 2005 The favorable outcome of human islet transplantation in Korea: Experiences of 10 autologous transplantations Lee BW11, Jee JH, Heo JS, Choi SH, Jang KT, Noh JH, Jeong IK, Oh SH, Ahn YR, Chae HY, Min YK, Chung JH, Lee MK, Lee MS, Kim KW.
    View PubMed
  • Thyroid. 2004 Oct;14(10):813-8. 2004 RET proto-oncogene mutations are restricted to codon 634 and 618 in Korean families with multiple endocrine neoplasia 2A Chung YJ11, Kim HH, Kim HJ, Min YK, Lee MS, Lee MK, Kim KW, Ki CS, Kim JW, Chung JH.
    View PubMed
  • Thyroid. 2004 Jan;14(1):29-33. 2004 Prevalence, clinical and ultrasonographic characteristics of thyroid incidentalomas Kang HW11, No JH, Chung JH, Min YK, Lee MS, Lee MK, Yang JH, Kim KW.
    View PubMed
  • Diabetes Res Clin Pract. 2002 May;56(2):107-13. 2002 First human trial of pancreatic islet allo-transplantation in Korea - focus on re-transplantation Yang TY11, Oh SH, Jeong IK, Seo IA, Oh EY, Kim SJ, Chung JH, Min YK, Lee MS, Lee MK, Kim KW, Do YS, Choo SW.
    View PubMed
  • 없음 2002 The stimulatory effect of IL-1 beta on the insulin secretion of rat pancreatic islet is not related with NOS pathway
    View PubMed
  • Diabetes Res Clin Pract. 2001 Mar;51(3):163-71. 2001 The effects of dexamethasone on insulin release and biosynthesis are dependent on the dose and duration of treatment Jeong IK11, Oh SH, Kim BJ, Chung JH, Min YK, Lee MS, Lee MK, Kim KW.
    View PubMed
  • Thyroid. 2001 Jan;11(1):73-80. 2001 Routine measurement of serum calcitonin is useful for early detection of medullary thyroid carcinoma in patients with nodular thyroid diseases Hahm JR11, Lee MS, Min YK, Lee MK, Kim KW, Nam SJ, Yang JH, Chung JH.
    View PubMed
  • Thyroid. 1999 Dec;9(12):1237-43. 1999 Detection of RET/PTC oncogene rearrangements in Korean papillary thyroid carcinomas Chung JH11, Hahm JR, Min YK, Lee MS, Lee MK, Kim KW, Nam SJ, Yang JH, Ree HJ.
    View PubMed